EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

ANALISIS MINIMALISASI BIAYA PENGGUNAAN OBAT ANTIDIABETIK PASIEN RAWAT INAP DIABETES MELITUS DENGAN HIPERTENSI DI RUMAH SAKIT PKU MUHAMMADIYAH GAMPING PERIODE JANUARI-JULI 2024

Nafiatul Khusna, Fitri Andriani Fatimah, Listiana Hidayati, Melia Eka Rosita

Jurnal Insan Farmasi Indonesia · 31.12.2025 · 8 (2) · 307-320

DOI: 10.36387/jifi.v8i2.2769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Jurnal Insan Farmasi Indonesia, online erschienen am 31.12.2025. Verfasst von Nafiatul Khusna und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus is a chronic disease with increasing prevalence globally. The prevalence of diabetes mellitus in the Special Region of Yogyakarta was 23.3% in 2022 and increased to 64.8% in 2023, with 17,050 sufferers in Sleman Regency. This high prevalence increases the risk of cardiovascular complications and increases the cost of treatment, which adds to the overall economic burden. The purpose of this study was to determine the characteristics of respondents, the profile of antidiabetic drugs, and the minimum cost of antidiabetic therapy for inpatients with diabetes mellitus and hypertension at PKU Muhammadiyah Gamping Hospital. The study was conducted using a descriptive design with retrospective secondary data collection from the medical records section for the period January-July 2024. Cost data were analyzed using the Cost Minimization Analysis (CMA) method. The results showed that the majority of patients were women aged 55–65 years with BPJS coverage. The most common single therapy was insulin novorapid flexpen (8 patients), while the most common combination therapy was metformin and novorapid flexpen (4 patients). The minimum therapy cost is Rp. 3,286,700 with the combination therapy group of insulin lantus and novorapid.

Zitieren

APA

Khusna, N., Fatimah, F. A., Hidayati, L., & Rosita, M. E. (2025). ANALISIS MINIMALISASI BIAYA PENGGUNAAN OBAT ANTIDIABETIK PASIEN RAWAT INAP DIABETES MELITUS DENGAN HIPERTENSI DI RUMAH SAKIT PKU MUHAMMADIYAH GAMPING PERIODE JANUARI-JULI 2024. Jurnal Insan Farmasi Indonesia, 8(2), 307-320. https://doi.org/10.36387/jifi.v8i2.2769

Vancouver

Khusna N, Fatimah FA, Hidayati L, Rosita ME. ANALISIS MINIMALISASI BIAYA PENGGUNAAN OBAT ANTIDIABETIK PASIEN RAWAT INAP DIABETES MELITUS DENGAN HIPERTENSI DI RUMAH SAKIT PKU MUHAMMADIYAH GAMPING PERIODE JANUARI-JULI 2024. Jurnal Insan Farmasi Indonesia. 2025;8(2):307-320. doi:10.36387/jifi.v8i2.2769

BibTeX
@article{Khusna2025,
  author = {Khusna, Nafiatul and Fatimah, Fitri Andriani and Hidayati, Listiana and Rosita, Melia Eka},
  title = {ANALISIS MINIMALISASI BIAYA PENGGUNAAN OBAT ANTIDIABETIK PASIEN RAWAT INAP DIABETES MELITUS DENGAN HIPERTENSI DI RUMAH SAKIT PKU MUHAMMADIYAH GAMPING PERIODE JANUARI-JULI 2024},
  journal = {Jurnal Insan Farmasi Indonesia},
  year = {2025},
  volume = {8},
  number = {2},
  pages = {307--320},
  doi = {10.36387/jifi.v8i2.2769}
}
Kostenlos starten →